Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid LeukemiaCheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong WeiAffiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, China
Keywords: Acute myeloid leukemia, Refractory/relapsed, Minimal residual disease, Lenalidomide, Interferon α, -1b, Interleukin-2
Yirmi Bir Akut Myeloid Lösemi Olgusunda İnterferon α-1b ve Interlökin-2 ile Birlikte Lenalidomid TedavisiCheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong WeiAffiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, China
Anahtar Kelimeler: Akut myeloid lösemi, Dirençli/nüks, Minimal kalıntı hastalık, Lenalidomid, İnterferon α, -1b, İnterlökin-2
Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong Wei. Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia. Turk J Hematol. 2021; 38(3): 230-232
Corresponding Author: Xudong Wei, China |
|